Federal Register / Vol. 87, No. 126 / Friday, July 1, 2022 / Notices 39521 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement to Fund India 

Council of Medical Research (IMCR) 

and ICMR Institutions: National 

Institute of Virology (NIV), Pune and 

National Institute of Epidemiology 

(NIE), Chennai; Correction 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice; correction. 

SUMMARY: The CDC published a 

document in the Federal Register of 

June 15, 2022, concerning a Notice of 

Award. The document contained 

incorrect funding amounts. 

FOR FURTHER INFORMATION CONTACT: 

Shana Eatman, Centers for Disease 

Control and Prevention, 1825 Century 

Center, MS V18–3, Atlanta, GA 30345, 

Telephone: 770–488–3933, E-Mail: 

DGHPNOFOs@cdc.gov 

SUPPLEMENTARY INFORMATION: 

Correction 

In the Federal Register of June 15, 

2022, in FR Doc. 2022–12850, on page 

36133, in the first column, in the 

SUMMARY, correct to read: 

SUMMARY:The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces 

three (3) separate awards within the 

government of India to include the 

Indian Council of Medical Research 

(ICMR) New Delhi, National Institute of 

Virology (NIV) and National Institute of 

Epidemiology (NIE). For ICMR New 

Delhi, the award is for approximately 

$8,165,000 with an expected total 

funding of approximately $24,495,000. 

For NIV, the award is for approximately 

$8,165,000 with an expected total 

funding of approximately $24,495,000. 

For NIE, the award is for approximately 

$8,165,000 with an expected total 

funding of approximately $24,495,000. 

The total 5-year period amount for the 

three recipients is $122,475,000. The 

awards will accelerate progress toward 

an India safe and secure from infectious 

disease threats through ICMR 

institutions’ focus on emerging and reemerging pathogens, including 

detecting, and controlling zoonotic 

disease outbreaks through a One Health 

approach; evaluating vaccine safety 

monitoring systems; capacitating the 

public health workforce in field 

epidemiology and outbreak response; 

and combating antimicrobial resistance. 

In the Federal Register of June 15, 

2022, in FR Doc. 2022–12850, on page 

36133, in the second column, Amount 

of Award, correct to read: 

Amount of Award: $8,165,000 in 

Federal Fiscal Year (FFY) 2022 funds 

per institution, with a total estimated 

$122,475,000 for the 5-year period of 

performance, subject to availability of 

funds. Please note, the NOFO funding 

strategy is as follows: $660,000 for Core 

Component 1, and $7,505,000 in 

Approved but Unfunded (ABU) 

Components for each recipient. 

Dated: June 28, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–14139 Filed 6–30–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Injury Prevention 

and Control (BSC, NCIPC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

of the Board of Scientific Counselors, 

National Center for Injury Prevention 

and Control (BSC, NCIPC or Board). 

This meeting is closed to the public. 

DATES: The meeting will be held on July 

26, 2022, from 1:00 p.m. to 5:00 p.m., 

EDT (CLOSED). 

ADDRESSES: Zoom Virtual Meeting 

FOR FURTHER INFORMATION CONTACT: 

Arlene Greenspan, DrPH, MPH, PT, 

Associate Director for Science, NCIPC, 

CDC, 4770 Buford Highway NE, 

Mailstop S–1069, Atlanta, Georgia 

30341; Telephone: (770) 488–1279; 

Email: ncipcbsc@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

meeting referenced above will be closed 

to the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, 

CDC, pursuant to Public Law 92–463 (5 

U.S.C. app. 2). 

Purpose: The Board will: (1) conduct, 

encourage, cooperate with, and assist 

other appropriate public health 

authorities, scientific institutions, and 

scientists in the conduct of research, 

investigations, experiments, 

demonstrations, and studies relating to 

the causes, diagnosis, treatment, control, 

and prevention of physical and mental 

diseases, and other impairments; (2) 

assist States and their political 

subdivisions in preventing and 

suppressing communicable and noncommunicable diseases and other 

preventable conditions and in 

promoting health and well-being; and 

(3) conduct and assist in research and 

control activities related to injury. The 

BSC, NCIPC makes recommendations 

regarding policies, strategies, objectives, 

and priorities; reviews progress toward 

injury prevention goals; and provides 

evidence in injury prevention-related 

research and programs. The Board also 

provides advice on the appropriate 

balance of intramural and extramural 

research, as well as the structure, 

progress, and performance of intramural 

programs. The Board provides guidance 

on extramural scientific program 

matters, including the: (1) review of 

extramural research concepts for 

funding opportunity announcements; 

(2) conduct of Secondary Peer Review of 

extramural research grants, cooperative 

agreements, and contract applications 

received in response to funding 

opportunity announcements as they 

relate to the Center’s programmatic 

balance and mission; (3) submission of 

secondary review recommendations to 

the Center Director of applications to be 

considered for funding support; (4) 

review of research portfolios; and (5) 

review of program proposals. 

Matters To Be Considered: The closed 

meeting will focus on the Secondary 

Peer Review of extramural research 

grant applications received in response 

to five (5) Notices of Funding 

Opportunities (NOFOs): RFA–CE–22– 

003—‘‘Rigorously Evaluating Programs 

and Policies to Prevent Child Sexual 

Abuse (CSA) (U01)’’; RFA–CE–22–005— 

‘‘Research Grants for Preventing 

Violence and Violence Related Injury 

(R01)’’; RFA–CE–22–006—‘‘Research 

Grants to Evaluate the Effectiveness of 

Physical Therapy-based Exercises and 

Movements Used to Reduce Older 

Adults Falls(U01)’’; RFA–CE–22–007— 

‘‘Reduce Health Disparities and Improve 

Traumatic Brain Injury (TBI) Related 

Outcomes Through the Implementation 

of CDC’s Pediatric Mild TBI Guideline’’; 

and RFA–CE–22–008—‘‘Using Data 

Linkage to Understand Suicide 

Attempts, Self-Harm and Unintentional 

Drowning Deaths (U01).’’ Agenda items 


khammond on DSKJM1Z7X2PROD with NOTICES